论文部分内容阅读
目的:研究肝动脉栓塞化疗治疗中晚期肝癌的疗效。方法:对118例经肝动脉栓塞化疗治疗的中晚期肝癌患者评价疗效并随访2a以上,观察其生存率。结果:完全缓解8例,部分缓解49例,轻微缓解44例,无变化17例,有效率达85.6%。1a生存率为66.9%,2a生存率为31.4%。结论:肝动脉栓塞化疗治疗中晚期肝癌疗效确切,副作用较少,易于在基层医院推广。
Objective: To study the efficacy of hepatic arterial chemoembolization in the treatment of advanced liver cancer. Methods: 118 patients with advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization were evaluated for efficacy and followed up for more than 2a. The survival rate was observed. Results: Complete remission in 8 cases, partial remission in 49 cases, slight remission in 44 cases, no change in 17 cases, the effective rate was 85.6%. 1a survival rate was 66.9%, 2a survival rate was 31.4%. Conclusion: Hepatic arterial chemoembolization in the treatment of advanced hepatocellular carcinoma is effective and has few side effects and is easy to be popularized in primary hospitals.